Apr 30, 2020 Chimerix, Inc. (CMRX) Stock Message Board - InvestorsHub Apr 29, 2020 CMRX Stock Price and Chart — NASDAQ:CMRX — TradingView DURHAM, N.C., April 29, 2020 (GLOBE NEWSWIRE) -- Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced the Company’s initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19 patients with acute lung injury (ALI). Chimerix, Inc. - CMRX - Stock Price Today - Zacks
AU AngloGold Ashanti Ltd. — Stock Price and ... - Stocktwits Real-time trade and investing ideas on AngloGold Ashanti Ltd. AU from the largest community of traders and investors. CMRX | Stock Snapshot - Fidelity
Chimerix, Inc. (CMRX) Stock Message Board - InvestorsHub Apr 29, 2020 CMRX Stock Price and Chart — NASDAQ:CMRX — TradingView DURHAM, N.C., April 29, 2020 (GLOBE NEWSWIRE) -- Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced the Company’s initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19 patients with acute lung injury (ALI). Chimerix, Inc. - CMRX - Stock Price Today - Zacks View Chimerix Inc CMRX investment & stock information. Get the latest Chimerix Inc CMRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. CMRX - Stock quote for CHIMERIX, INC. - MSN Money
Chimerix Inc (NASDAQ:CMRX) announced its quarterly earnings data on Thursday, May, 7th. The biopharmaceutical company reported ($0.17) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.15) by $0.02.
CMRX Stock Price, Forecast & News (Chimerix) | MarketBeat Chimerix Inc (NASDAQ:CMRX) announced its quarterly earnings data on Thursday, May, 7th. The biopharmaceutical company reported ($0.17) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.15) by $0.02. Chimerix, Inc. (CMRX) Interactive Stock Chart - Yahoo Finance Chimerix (CMRX) Reports Q1 Loss, Lags Revenue Estimates. Chimerix (CMRX) delivered earnings and revenue surprises of -13.33% and -17.27%, respectively, for the quarter ended March 2020.